Sartorius Stedim Biotech Issues Capital Structure Update

Sartorius Stedim Biotech SA has released a statement regarding its shares and voting rights. As of December 31, 2025, the company's issued capital totaled 97,330,405 shares. The firm reported a total of 164,793,739 theoretical voting rights, inclusive of treasury shares. The net voting rights, excluding these shares, amounted to 164,759,753. This announcement aligns with Article L 233-8-II of the French Code of Commerce and AMF's Article 223-6. The company is headquartered in Aubagne, France, and listed under the Euronext ticker DIM.